aTyr Pharma | LIFE - Ebit


aTyr Pharma reported $24.47M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Ardelyx USD 5.1M 2.02M Dec/2025
aTyr Pharma USD 24.47M 24.7M Dec/2025
Biogen USD 659.6M 157M Sep/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD 56.04M 63.94M Dec/2025
CSL USD 2.64B 116M Dec/2025
Curis USD -7.88M 4.31M Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Grifols EUR 320.55M 91.01M Dec/2025
Novartis USD 4.06B 530M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Xoma USD -10.08M 4.4M Jun/2024